Altogether, our **data** demonstrate that the substrate promiscuity of both 4CL5 and HCBT can be exploited for biological synthesis of structurally diverse cinnamoyl, dihydrocinnamoyl, and benzoyl anthranilates of potential pharmaceutical value.